Your browser doesn't support javascript.
loading
Time-to-cure and cure proportion in solid cancers in France. A population based study.
Romain, Gaëlle; Boussari, Olayidé; Bossard, Nadine; Remontet, Laurent; Bouvier, Anne-Marie; Mounier, Morgane; Iwaz, Jean; Colonna, Marc; Jooste, Valérie.
Afiliación
  • Romain G; Registre Bourguignon des Cancers Digestifs, Dijon, France; Centre Hospitalier Universitaire de Dijon Bourgogne, Dijon, France; INSERM, LNC UMR1231, Dijon, France; Université de Bourgogne Franche-Comté, Dijon, France.
  • Boussari O; Registre Bourguignon des Cancers Digestifs, Dijon, France; INSERM, LNC UMR1231, Dijon, France; Université de Bourgogne Franche-Comté, Dijon, France; Laboratoire d'Excellence LabEX LipSTIC, ANR-11-LABX-0021, Dijon, France.
  • Bossard N; Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France; Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique Santé, Pierre-Bénite, France.
  • Remontet L; Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France; Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique Santé, Pierre-Bénite, France.
  • Bouvier AM; Registre Bourguignon des Cancers Digestifs, Dijon, France; Centre Hospitalier Universitaire de Dijon Bourgogne, Dijon, France; INSERM, LNC UMR1231, Dijon, France; Université de Bourgogne Franche-Comté, Dijon, France.
  • Mounier M; Centre Hospitalier Universitaire de Dijon Bourgogne, Dijon, France; INSERM, LNC UMR1231, Dijon, France; Université de Bourgogne Franche-Comté, Dijon, France; Registre des Hémopathies Malignes de Côte d'Or, Dijon, France.
  • Iwaz J; Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France; Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique Santé, Pierre-Bénite, France.
  • Colonna M; Registre du Cancer de l'Isère, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
  • Jooste V; Registre Bourguignon des Cancers Digestifs, Dijon, France; Centre Hospitalier Universitaire de Dijon Bourgogne, Dijon, France; INSERM, LNC UMR1231, Dijon, France; Université de Bourgogne Franche-Comté, Dijon, France. Electronic address: valerie.jooste@u-bourgogne.fr.
Cancer Epidemiol ; 60: 93-101, 2019 06.
Article en En | MEDLINE | ID: mdl-30933890
BACKGROUND: In cancer care, the cure proportion (P) and time-to-cure (TTC) are important indicators for practitioners, patients, and healthcare policy makers. The recent definition of TTC as the time at which the probability of belonging to the cured group reaches 95% was used for the first time. METHODS: The data stem from the common database of French cancer registries including 335,358 solid tumours diagnosed between 1995 and 2009 at 27 sites. P and TTC were estimated through a flexible parametric net survival cure model for each cancer site, sex, and age at diagnosis with acceptable assumption of cure (excess mortality rate ≤0.05). RESULTS: TTC was ≤5 years and P was >80% for skin melanoma and thyroid and testis cancers. It was 0 for testis cancer in men <55 and for thyroid cancer in men <45 and women <65. TTC was between 5 and 10 years for all digestive cancers except small intestine and all gynaecologic cancers except breast. It was ≥10 years in prostate, breast, and urinary tract. The range of P according to age and sex was 37-79% for urinary tract 72-88% for prostate and breast, 4-16% for pancreatic and 47-62% for colorectal cancer. CONCLUSION: Time-to-cure was estimated for the first time from a large national database and individual probabilities of cure. It was 0 in the younger patients with testis or thyroid cancer and <12 years in most cancer sites. These results should help improve access to credit and insurance for patients still alive past the estimated TTCs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Asunto de la revista: EPIDEMIOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Asunto de la revista: EPIDEMIOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos